Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

詳細記述

書誌詳細
主要な著者: Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
フォーマット: 論文
言語:Russian
出版事項: «REMEDIUM GROUP» Ltd. 2023-01-01
シリーズ:Атеротромбоз
主題:
active cancer
multifocal atherosclerosis
d-dimer
gdf-15
vegf-a
prognosis determining outcomes
オンライン･アクセス:https://www.aterotromboz.ru/jour/article/view/287

インターネット

https://www.aterotromboz.ru/jour/article/view/287

類似資料